ATE495238T1 - Iin vitro methode um eine potentielle reaktion eines tieres an einen agenten zu bestimmen - Google Patents

Iin vitro methode um eine potentielle reaktion eines tieres an einen agenten zu bestimmen

Info

Publication number
ATE495238T1
ATE495238T1 AT06848082T AT06848082T ATE495238T1 AT E495238 T1 ATE495238 T1 AT E495238T1 AT 06848082 T AT06848082 T AT 06848082T AT 06848082 T AT06848082 T AT 06848082T AT E495238 T1 ATE495238 T1 AT E495238T1
Authority
AT
Austria
Prior art keywords
dcs
cultured
transwell
populations
blood monocytes
Prior art date
Application number
AT06848082T
Other languages
English (en)
Inventor
Donald Drake
David Moe
Conan Li
Heather Fahlenkamp
Guzman Sanchez-Schmitz
Russell Higbee
Robert Parkhill
William Warren
Original Assignee
Vaxdesign Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vaxdesign Corp filed Critical Vaxdesign Corp
Application granted granted Critical
Publication of ATE495238T1 publication Critical patent/ATE495238T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4615—Dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
    • A61K39/4622—Antigen presenting cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4641—Fungal antigens, e.g. Trichophyton, Aspergillus or Candida
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00—Constructional details, e.g. recesses, hinges
    • C12M23/02—Form or structure of the vessel
    • C12M23/12—Well or multiwell plates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00—Constructional details, e.g. recesses, hinges
    • C12M23/20—Material Coatings
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M25/00—Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
    • C12M25/02—Membranes; Filters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M25/00—Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
    • C12M25/14—Scaffolds; Matrices
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/28—Vascular endothelial cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Sustainable Development (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Clinical Laboratory Science (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT06848082T 2005-12-21 2006-12-21 Iin vitro methode um eine potentielle reaktion eines tieres an einen agenten zu bestimmen ATE495238T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75203305P 2005-12-21 2005-12-21
PCT/US2006/049128 WO2007076061A1 (en) 2005-12-21 2006-12-21 A porous membrane device that promotes the differentiation of monocytes into dendritic cells

Publications (1)

Publication Number Publication Date
ATE495238T1 true ATE495238T1 (de) 2011-01-15

Family

ID=37963795

Family Applications (2)

Application Number Title Priority Date Filing Date
AT06848082T ATE495238T1 (de) 2005-12-21 2006-12-21 Iin vitro methode um eine potentielle reaktion eines tieres an einen agenten zu bestimmen
AT10151003T ATE531793T1 (de) 2005-12-21 2006-12-21 Eine poröse membran gerät, das die differenzierung von monozyten in dendritische zellen fördert

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT10151003T ATE531793T1 (de) 2005-12-21 2006-12-21 Eine poröse membran gerät, das die differenzierung von monozyten in dendritische zellen fördert

Country Status (9)

Country Link
US (2) US20070178076A1 (de)
EP (2) EP2199384B1 (de)
JP (1) JP2009521228A (de)
AT (2) ATE495238T1 (de)
AU (1) AU2006330951B2 (de)
CA (2) CA2847310A1 (de)
DE (1) DE602006019638D1 (de)
IL (1) IL192090A (de)
WO (1) WO2007076061A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7771999B2 (en) * 2004-04-28 2010-08-10 Vaxdesign Corp. Disease model incorporation into an artificial immune system (AIS)
US7785806B2 (en) 2004-04-28 2010-08-31 Vaxdesign Corporation Method for determining the immunogenicity of an antigen
US7709256B2 (en) * 2004-04-28 2010-05-04 Vaxdesign Corp. Disease model incorporation into an artificial immune system (AIS)
US8071373B2 (en) * 2004-04-28 2011-12-06 Sanofi Pasteur Vaxdesign Corp. Co-culture lymphoid tissue equivalent (LTE) for an artificial immune system (AIS)
US8030070B2 (en) * 2004-04-28 2011-10-04 Sanofi Pasteur Vaxdesign Corp. Artificial lymphoid tissue equivalent
US7785883B2 (en) 2004-04-28 2010-08-31 Vax Design Corp. Automatable artificial immune system (AIS)
US7855074B2 (en) 2004-04-28 2010-12-21 Vaxdesign Corp. Artificial immune system: methods for making and use
US8298824B2 (en) 2004-04-28 2012-10-30 Sanofi Pasteur Vaxdesign Corporation Methods of evaluating a test agent in a diseased cell model
US8003387B2 (en) 2005-12-21 2011-08-23 Sanofi Pasteur Vaxdesign Corp. In vitro germinal centers
CA2847310A1 (en) * 2005-12-21 2007-07-05 Sanofi Pasteur Vaxdesign Corporation A porous membrane device that promotes the differentiation of monocytes into dendritic cells
EP2043695B8 (de) * 2006-06-27 2012-02-29 Sanofi Pasteur VaxDesign Corporation Modelle für die bewertung von impfstoffen
WO2009048661A1 (en) * 2007-07-16 2009-04-16 Vaxdesign Corporation Artificial tissue constructs comprising alveolar cells and methods for using the same
AU2010225438A1 (en) * 2009-03-17 2011-10-13 The Heart Research Institute Ltd Method of cell differentiation and uses therefor in screening, diagnosis and therapy
JP2013517943A (ja) * 2010-01-29 2013-05-20 モレキュラー・インプリンツ・インコーポレーテッド ナノ粒子を形成するためのナノインプリントリソグラフィプロセス
JP2015509382A (ja) 2012-03-07 2015-03-30 チルドレンズ メディカル センター コーポレーション 組織構築体およびその使用
US9423234B2 (en) 2012-11-05 2016-08-23 The Regents Of The University Of California Mechanical phenotyping of single cells: high throughput quantitative detection and sorting
FR3045664A1 (fr) * 2015-12-17 2017-06-23 Oreal Membrane pour tissu reconstruit comprenant des pores de plusieurs diametres
CA3035059C (en) * 2016-09-08 2023-07-11 Sanofi Pasteur Vaxdesign Corp. In vitro neonatal biomimetic (nmimic) model and methods of using same
KR101986092B1 (ko) * 2016-09-13 2019-06-05 대한뉴팜(주) 유두진피 섬유아세포의 고순도 분리 방법
CA3068364C (en) * 2017-06-26 2023-09-26 BIOHOPE Scientific Solutions for Human Health S.L. Method for predicting and monitoring clinical response to immunomodulatory therapy
CN112221543B (zh) * 2019-07-15 2024-05-10 京东方科技集团股份有限公司 细胞片层转移器件、运输装置和转移细胞片层的方法

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5160490A (en) * 1986-04-18 1992-11-03 Marrow-Tech Incorporated Three-dimensional cell and tissue culture apparatus
US5720937A (en) * 1988-01-12 1998-02-24 Genentech, Inc. In vivo tumor detection assay
US5008116A (en) * 1988-11-14 1991-04-16 Frederick Cahn Immunostimulatory microsphere
US5562910A (en) * 1989-09-25 1996-10-08 University Of Utah Research Foundation Vaccine compositions and method for enhancing an immune response
US5188959A (en) * 1989-09-28 1993-02-23 Trustees Of Tufts College Extracellular matrix protein adherent t cells
US5827641A (en) * 1992-11-13 1998-10-27 Parenteau; Nancy L. In vitro cornea equivalent model
US5695996A (en) * 1994-09-23 1997-12-09 The United States Of America As Represented By The Department Of Health And Human Services Artificial organ culture system
US6479258B1 (en) * 1995-12-07 2002-11-12 Diversa Corporation Non-stochastic generation of genetic vaccines
US5739001A (en) * 1996-10-29 1998-04-14 E. I. Du Pont De Nemours And Company Solid phase cell-based assay
US6177282B1 (en) * 1997-08-12 2001-01-23 Mcintyre John A. Antigens embedded in thermoplastic
US6274378B1 (en) * 1997-10-27 2001-08-14 The Rockefeller University Methods and compositions for obtaining mature dendritic cells
US6835550B1 (en) * 1998-04-15 2004-12-28 Genencor International, Inc. Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins
US20020155108A1 (en) * 1998-05-04 2002-10-24 Biocrystal, Ltd. Method for ex vivo loading of antigen presenting cells with antigen, and a vaccine comprising the loaded cells
EP1232181B1 (de) * 1999-11-12 2013-03-27 Fibrogen, Inc. Rekombinante gelatinen
CN1423523A (zh) * 1999-11-17 2003-06-11 罗切斯特大学 来自人体内的免疫***
US6479064B1 (en) * 1999-12-29 2002-11-12 Children's Medical Center Corporation Culturing different cell populations on a decellularized natural biostructure for organ reconstruction
US6541225B1 (en) * 2000-01-26 2003-04-01 Raven Biotechnologies, Inc. Methods and compositions for generating human monoclonal antibodies
US20050164388A1 (en) * 2001-02-07 2005-07-28 Young-Sook Son Method of isolating epithelial cells, method of preconditioning cells, and methods of preparing bioartificial skin and dermis with the epithelial cells and preconditioned cells
EP1437147B1 (de) * 2001-09-25 2012-06-27 National Institute for Environmental Studies Verfahren zur herstellung einer grundmembran
FR2833271B1 (fr) * 2001-12-10 2004-09-17 Coletica Production de cellules dendritiques in vitro a partir de monocytes cd14+, pour notamment la realisation de modeles cellulaires et/ou tissulaires en suspension, en monocouches et tridimentionnels; utilisation de ces modeles
GB0130789D0 (en) * 2001-12-21 2002-02-06 King S College London Application of spores
EP1490088A4 (de) * 2002-03-18 2006-02-15 Sciperio Inc Dentritische zellknoten
AU2003226067A1 (en) * 2002-04-11 2003-10-27 Cyclex, Inc. Method for monitoring the immune response and predicting clinical outcomes in transplant recipients
US20040009943A1 (en) * 2002-05-10 2004-01-15 Inex Pharmaceuticals Corporation Pathogen vaccines and methods for using the same
US20050191743A1 (en) * 2002-10-03 2005-09-01 Wu J.H. D. Three-dimensional peripheral lymphoid organ cell cultures
US20040109876A1 (en) * 2002-11-25 2004-06-10 Kureha Chemical Industry Co., Ltd. Vaccine composition, HIV-infection suppression factor and method for the vaccination against HIV
AU2005237588B2 (en) * 2004-04-28 2010-07-08 Massachusetts Institute Of Technology Artificial immune system: methods for making and use
US7771999B2 (en) * 2004-04-28 2010-08-10 Vaxdesign Corp. Disease model incorporation into an artificial immune system (AIS)
US7785806B2 (en) * 2004-04-28 2010-08-31 Vaxdesign Corporation Method for determining the immunogenicity of an antigen
US20060275270A1 (en) * 2004-04-28 2006-12-07 Warren William L In vitro mucosal tissue equivalent
US7855074B2 (en) * 2004-04-28 2010-12-21 Vaxdesign Corp. Artificial immune system: methods for making and use
US8030070B2 (en) * 2004-04-28 2011-10-04 Sanofi Pasteur Vaxdesign Corp. Artificial lymphoid tissue equivalent
US8071373B2 (en) * 2004-04-28 2011-12-06 Sanofi Pasteur Vaxdesign Corp. Co-culture lymphoid tissue equivalent (LTE) for an artificial immune system (AIS)
US20070141552A1 (en) * 2004-04-28 2007-06-21 Warren William L Automatable artificial immune system (AIS)
US7785883B2 (en) * 2004-04-28 2010-08-31 Vax Design Corp. Automatable artificial immune system (AIS)
CA2847310A1 (en) * 2005-12-21 2007-07-05 Sanofi Pasteur Vaxdesign Corporation A porous membrane device that promotes the differentiation of monocytes into dendritic cells
US8003387B2 (en) * 2005-12-21 2011-08-23 Sanofi Pasteur Vaxdesign Corp. In vitro germinal centers
EP2043695B8 (de) * 2006-06-27 2012-02-29 Sanofi Pasteur VaxDesign Corporation Modelle für die bewertung von impfstoffen
WO2009009424A2 (en) * 2007-07-06 2009-01-15 Vaxdesign Corporation Rapid generation of t cell-independent antibody responses to t cell-dependent antigens

Also Published As

Publication number Publication date
EP2199384B1 (de) 2011-11-02
EP1963491B1 (de) 2011-01-12
JP2009521228A (ja) 2009-06-04
AU2006330951B2 (en) 2012-04-05
WO2007076061A1 (en) 2007-07-05
ATE531793T1 (de) 2011-11-15
EP1963491A1 (de) 2008-09-03
DE602006019638D1 (de) 2011-02-24
US20100105135A1 (en) 2010-04-29
US20070178076A1 (en) 2007-08-02
IL192090A0 (en) 2008-12-29
CA2634119C (en) 2015-02-24
EP2199384A1 (de) 2010-06-23
CA2847310A1 (en) 2007-07-05
CA2634119A1 (en) 2007-07-05
IL192090A (en) 2012-01-31
AU2006330951A1 (en) 2007-07-05

Similar Documents

Publication Publication Date Title
ATE495238T1 (de) Iin vitro methode um eine potentielle reaktion eines tieres an einen agenten zu bestimmen
Wallace et al. Tracking antigen‐driven responses by flow cytometry: monitoring proliferation by dye dilution
JP5795699B2 (ja) 人工免疫システム：作製および使用方法
US11590214B2 (en) Antigen presenting scaffolds for immune-cell manipulation
HK1161977A1 (zh) 增加人樹突細胞對外源性抗原的 類遞呈的方法
Gyülvészi et al. IL‐23‐driven encephalo‐tropism and Th17 polarization during CNS‐inflammation in vivo
CN1423523A (zh) 来自人体内的免疫***
CN101314764A (zh) 一种体外扩增自然杀伤细胞的方法
Lanzinger et al. Ambivalent effects of dendritic cells displaying prostaglandin E 2‐induced indoleamine 2, 3‐dioxygenase
Livingston et al. CD4 T-helper cell cytokine phenotypes and antibody response following tetanus toxoid booster immunization
Chiu et al. The innate pulmonary granuloma: characterization and demonstration of dendritic cell recruitment and function
Curnow et al. In vitro developmental potential of macaque oocytes, derived from unstimulated ovaries, following maturation in the presence of glutathione ethyl ester
Anton et al. Generation of dendritic cells from peripheral blood adherent cells in medium with human serum
BR112020024183A2 (pt) Estruturas com moléculas de mhc estabilizadas para manipulação de células imunes
Adkins et al. The primary responses of murine neonatal lymph node CD4+ cells are Th2‐skewed and are sufficient for the development of Th2‐biased memory
Angel et al. Comprehensive analysis of MHC‐II expression in healthy human skin
ATE456649T1 (de) Verwendung allogener zelllinien zur beladung antigen-präsentierender zellen zur auslösung von immunantworten
Sjaastad et al. Reduced T Cell Priming in Microbially Experienced “Dirty” Mice Results from Limited IL-27 Production by XCR1+ Dendritic Cells
Delles et al. A simple method for the purification of human peripheral blood antigen presenting cells (dendritic cells, monocytes/macrophages, and B lymphocytes)
Toulmin et al. Type II alveolar cells with constitutive expression of MHCII and limited antigen presentation capacity contribute to improved respiratory viral disease outcomes
Jones Assays on the influence of biomaterials on allogeneic rejection in tissue engineering
Schwenck In vivo imaging of the regulatory mechanisms in acute and chronic delayed type hypersensitivity reactions
Benítez et al. Novel noninvasive assays to predict transplantation rejection and tolerance: enumeration of cytokine-producing alloreactive T cells
Alsén et al. Antigen-presenting B cells program the efferent lymph T helper cell response
AR124432A1 (es) Procesamiento de linfocitos infiltrantes de tumor

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties